Literature DB >> 7489808

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

N M Siafakas, P Vermeire, N B Pride, P Paoletti, J Gibson, P Howard, J C Yernault, M Decramer, T Higenbottam, D S Postma.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7489808     DOI： 10.1183/09031936.95.08081398

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  210 in total

Review 1.  Home treatment of COPD exacerbations.

Authors:  D S Postma; N H Ten Hacken; H A Kerstjens; G H Koëter
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Stable chronic obstructive pulmonary disease.

Authors:  H A Kerstjens
Journal:  BMJ       Date:  1999-08-21

Review 3.  Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

4.  Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations.

Authors: 
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

5.  How do patients conceptualize chronic obstructive pulmonary disease?

Authors:  R E Goldman; L Mennillo; P Stebbins; D R Parker
Journal:  Chron Respir Dis       Date:  2016-12-19       Impact factor: 2.444

6.  Long-term effects of a maintenance program after supervised or self-monitored training programs in patients with COPD.

Authors:  L Puente-Maestu; M Luisa Sánz; P Sánz; Ruíz J M de Oña; A Arnedillo; R Casaburi
Journal:  Lung       Date:  2003       Impact factor: 2.584

7.  Estimation of expiratory time constants via fuzzy clustering.

Authors:  Marlies S Lourens; Lejla Ali; Bart van den Berg; Anton F M Verbraak; Jan M Bogaard; Henk C Hoogsteden; Robert Babuska
Journal:  J Clin Monit Comput       Date:  2002-01       Impact factor: 2.502

8.  Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years.

Authors:  Georgios Stratelis; Per Jakobsson; Siguard Molstad; Olle Zetterstrom
Journal:  Br J Gen Pract       Date:  2004-03       Impact factor: 5.386

9.  Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.

Authors:  Diana C Grootendorst; Stefanie A Gauw; Renate M Verhoosel; Peter J Sterk; Jeannette J Hospers; Dirk Bredenbröker; Thomas D Bethke; Pieter S Hiemstra; Klaus F Rabe
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

10.  Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).

Authors:  T R Schermer; J E Jacobs; N H Chavannes; J Hartman; H T Folgering; B J Bottema; C van Weel
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.